 VANCOUVER, British Columbia SEATTLE--BUSINESS WIRE--Zymeworks Inc. NYSE: ZYME, a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in upcoming investor conferences: Stifel 2022 Healthcare Conference. Zymeworks management will participate in one-on-one meetings and present on November 15th 16th in New York, NY. Jefferies London Healthcare Conference. Zymeworks management will participate 